96 Publications (Page 1 of 4)
2024
Human melanoma cell lines that possess wild-type BRAF alleles but are dependent on ERBB4 and ERBB2. bioRxiv
Recombinant retroviral expression vectors that encode dominant-negative alleles of EGFR and ERBB2
protocols.io. | Journal Article
Recombinant retroviral vectors that express EGF, TGF alpha, NRG2 beta, and the NRG2 beta Q43L mutant
protocols.io. | Journal Article
Stable Transfection of Plasmid DNA into Adherent Rodent Cell Lines Using Calcium Phosphate
protocols.io. | Journal Article
2023
A recombinant retroviral expression vector (pLXSN-HygR) based on pLXSN that confers resistance to hygromycin and pLXSN-HygR derivatives that encode EGFR, ERBB2, or ERBB3
protocols.io. | Journal Article
A recombinant retroviral expression vector (pLXSN-HygR) based on pLXSN that confers resistance to hygromycin and pLXSN-HygR derivatives that encode EGFR, ERBB2, or ERBB3 v1
Cell Culture Reagents and Sources – 2023-08-30
protocols.io. | Journal Article
Recombinant retroviral expression vectors based on pLXSN that encode EGFR, ERBB2, ERBB3, and ERBB4
protocols.io. | Journal Article
Recombinant retroviral expression vectors based on pLXSN that encode EGFR, ERBB2, ERBB3, and ERBB4 v1
2022
ERBB4 Drives the Proliferation of BRAF-WT Melanoma Cell LinesLucas, L.M.⋅Cullum, R.L.⋅Dwivedi, V.⋅Markham, J.A.⋅Woggerman, J.N.⋅Kelley, C.M.⋅Knerr, E.L.⋅Cook, L.J.⋅Lucas, H.C.⋅Waits, D.S.⋅Ghosh, T.M.⋅Halanych, K.M.⋅Gupta, R.B. and Riese, D.J.Cold Spring Harbor Laboratory
\lessi\greaterERBB4\less/i\greater Mutant Alleles May Drive \lessi\greaterBRAF\less/i\greater WT MelanomasLucas, Lauren M.⋅Cullum, Richard L.⋅Markham, Jessica A.⋅Woggerman, Joelle N.⋅Dwivedi, Vipasha⋅Mohamedelhassan, Rania H.⋅Cook, Laura J.⋅Kelley, Connor M.⋅Knerr, Elizabeth L.⋅Kaufmann, David P.⋅Jacobi, Megan A.⋅Taylor, Darby C.⋅Rael, Cristina C.⋅Waits, Damien S.⋅Ghosh, Taraswi M.⋅Halanych, Kenneth M.⋅Gupta, Ram B. and Riese, David J.Cold Spring Harbor Laboratory
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein. Pharmacological reviews
2021
The Simulated Random Assignment of Missense Mutations Throughout a Gene of Interest Can Determine Whether Missense Mutations Found in That Gene in a Population of Tumor Genomes Are Non-Randomly Distributed
The Simulated Random Assignment of Missense Mutations Throughout a Gene of Interest Can Determine Whether Missense Mutations Found in That Gene in a Population of Tumor Genomes Are Non-Randomly Distributed v1Cullum, Richard L and II, David J RieseZappyLab, Inc.
2020
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeuticsCullum, Richard L⋅Cullum, Richard L⋅Lucas, Lauren M⋅Lucas, Lauren M⋅Senfeld, Jared I⋅Senfeld, Jared I⋅Piazza, John T⋅Piazza, John T⋅Neel, Logan T⋅Neel, Logan T⋅Whig, Kanupriya⋅Whig, Kanupriya⋅Zhai, Ling⋅Zhai, Ling⋅Harris, Mackenzie H⋅Harris, Mackenzie H⋅Rael, Cristina C⋅Rael, Cristina C⋅Taylor, Darby C⋅Taylor, Darby C⋅Cook, Laura J⋅Cook, Laura J⋅Kaufmann, David P⋅Kaufmann, David P⋅Mill, Christopher P⋅Mill, Christopher P⋅Jacobi, Megan A⋅Jacobi, Megan A⋅Smith, Forrest T⋅Smith, Forrest T⋅Suto, Mark⋅Suto, Mark⋅Bostwick, Robert⋅Bostwick, Robert⋅Gupta, Ram B⋅Gupta, Ram B⋅David, Allan E⋅David, Allan E⋅Riese, David J and Riese, David JPLoS One, vol. 15, (no. 12), Dec 2020.
| Journal Article
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in CancerShi, Yi⋅Riese, David J. and Shen, JianzhongFrontiers Media SA
2017
Abstract 1245: Screening methodologies for the discovery of small molecule melanoma therapeutics targeted at the ErbB4 receptor tyrosine kinaseCullum, Richard L⋅Cullum, Richard L⋅Piazza, John T⋅Piazza, John T⋅Senfeld, Jared I⋅Senfeld, Jared I⋅Neel, Logan T⋅Neel, Logan T⋅Gupta, Ram B⋅Gupta, Ram B⋅David, Allan E⋅David, Allan E⋅Riese, David J and Riese, David JCancer Research, vol. 77, (no. 13 Supplement), pp. 1245, 2017-07-01.
| Journal Article
Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancerKabir, Farruk M. Lutful⋅DeInnocentes, Patricia⋅Agarwal, Payal⋅Mill, Christopher P⋅Riese, David J and Bird, R. CurtisJournal of Veterinary Science, vol. 18, (no. 2), pp. 158, 2017-00-00.
| Journal Article
2016
Abstract 1353: Validation and implementation of screens for partial agonists and antagonists of the ErbB4/HER4 receptor tyrosine kinase: Targeted melanona drug discoveryCullum, Richard⋅David, Allan and Riese, David JCancer Research, vol. 76, (no. 14 Supplement), pp. 1353, 2016-07-15.
| Journal Article
Expression and purification of HER2 extracellular domain proteins in Schneider2 insect cellsKanthala, Shanthi⋅Kanthala, Shanthi⋅Mill, Christopher P⋅Mill, Christopher P⋅Riese, David J⋅Riese, David J⋅Jaiswal, Mihir⋅Jaiswal, Mihir⋅Jois, Seetharama and Jois, SeetharamaProtein Expression and Purification, vol. 125, pp. 33, September 2016.
| Journal Article
2015
Abstract B17: A high-throughput screening process for the discovery of melanoma chemotherapeutics targeted at the ErbB4 receptor tyrosine kinaseCullum, Richard L⋅Gupta, Ram B and Riese, David JCancer Research, vol. 75, (no. 14 Supplement), pp. B17, 2015-07-15.
| Journal Article
2014
Epiregulin: Roles in normal physiology and cancerRiese, David J and Cullum, Richard LSeminars in Cell and Developmental Biology, vol. 28, pp. 56, April 2014.
| Journal Article
2013
Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.Nickerson, Nicole K⋅Mill, Christopher P⋅Wu, Hsin-Jung⋅Riese, David J and Foley, JohnOncology research, vol. 20, (no. 7), pp. 303-17, 2013.
| Journal Article
Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 MutantGallo, Richard M⋅Bryant, Ianthe N⋅Mill, Christopher P⋅Kaverman, Steven⋅Riese, David J and others(pp. 10). NIH Public Access
Team-Based Learning in US Colleges and Schools of PharmacyAllen, Rondall E⋅Copeland, Jeffrey⋅Franks, Andrea S⋅Karimi, Reza⋅McCollum, Marianne⋅Riese, David J and othersAmerican Association of Colleges of Pharmacy